Polyethylene glycol-superoxide dismutase, a conjugate in search of exploitation

Advanced Drug Delivery Reviews

Volumn 54, Issue 4, 2002, Pages 587-606

  Veronese, Francesco M ^a   Caliceti, Paolo ^a   Schiavon, Oddone ^a   Sergi, Mauro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Catalase; Ischemia and reperfusion injury; PEG SOD; Reactive oxygen species; Superoxide dismutase; Superoxide ion

Indexed keywords

BLOOD; ENZYMES; ESCHERICHIA COLI; OXIDATION; PATHOLOGY; TOXICITY;

CONJUGATE REMOVAL;

POLYETHYLENE GLYCOLS;

LIPOSOME; SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE MACROGOL;

ANALYTIC METHOD; BRAIN ISCHEMIA; DRUG ACTIVITY; DRUG ANTIGENICITY; DRUG BINDING SITE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG HALF LIFE; ENZYME ACTIVITY; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOGENICITY; KIDNEY ISCHEMIA; LIVER ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TISSUE SPECIFICITY;

EID: 0037124547     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(02)00029-7     Document Type: Article

References (193)

1. Mechanisms of endothelial cell injury in acute inflammation
2. Pulmonaty strategies of antioxidant defense
3. Neutrophil adhesion to endothelial cells impairs the effects of catalase and glutathione in preventing endothelial injury
4. Free radicals and tissue injury
5. Approaches to prevention of asbestos-induced lung disease using polyethylene glycol (PEG)-conjugated catalase
6. Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis
7. Studies on the clinical and laboratory pharmacology of drug formulations of bovine Cu-Zn superoxide dismutase (orgotein)
8. Orgotein efficacy in ameliorating side effects due to radiation therapy: Double-blind, placebo-controlled trial in patients with bladder tumors
9. Effect of superoxide dismutase on glomerular nephritis
10. Superoxide dismutase enhances recovery following myocardial ischemia/reperfusion in vivo and in vitro
11. Orgotein: A new anti-inflammatory metalloprotein drug: Preliminary evaluation of clinical efficacy and safety in degenerative joint disease
12. Orgotein, the drug version of bovine Cu-Zn superoxide dismutase II. A summary account of clinical trials in man and animals
13. Effect of intra-articular orgotein versus a corticosteroid on rheumatoid arthritis of the knee
14. Orgotein: A new anti-inflammatory metalloprotein drug evaluation of clinical efficacy and safety in inflammatory conditions of the urinary tract
15. Ten years of clinical experience with SOD treatment of inflammatory disorders
16. Therapeutic benefits of oxygen radical scavenger treatments remain unproven
17. Fate of superoxide dismutase in mice following oral route of administration
18. Recombinant-human superoxide dismutase attenuates endotoxin-induced lung injury in awake sheep
19. Administration of bovine superoxide dismutase fails to prevent chronic pulmonary sequelae of neonatal oxygen exposure in the rat
20. Effect of CuZnSOD on endothelium-dependent vasodilation in patients with essential hypertension
21. Superoxide dismutase and catalase do not affect the pulmonary hypertensive response to group B Streptococcus in the lamb
22. Stabilization of substances in circulation
23. Reduction of immunogenicity and extension of circulation half-life of peptides and proteins
24. Pharmacokinetics of peptide and protein drug
25. Treatment of inflammatory arthritis with oxygen radical scavengers
26. Safety evaluation of free radical scavengers PEG-catalase and PEG-superoxide dismutase
27. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase
28. Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase
29. Protection against pulmonary oxygen toxicity in rats by the intratracheal administration of liposome-encapsulated superoxide dismutase or catalase
30. La superoxyde dismutase et la pathologie des radicaux libres
31. Treatment with liposomal superoxide dismutase of patients with Kawasaki disease
32. Effects of superoxide dismutase encapsulated in liposomes or conjugated with polyethylene glycol on neutrophils bactericidal activity in vitro and bacterial clearance in vivo
33. Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen injury
34. 2 toxicity
35. Endocytosis-independent uptake of liposome-encapsulated superoxide dismutase prevents the killing of cultured hepatocytes by tert-butyl hydroperoxide
36. Effect of encapsulation in liposomes on the anti-inflammatory properties of superoxide dismutase after oral administration
37. Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen
38. Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis
39. Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusion
40. Effect of native and modified forms of superoxide dismutase and catalase on experimental silicosis in rats
41. Biodistribution of a polyethylene glycol-modified superoxide dismutase in mice and its effect on myocardial ischemia treatment in rats
42. Physico-chemical and biological properties of monofunctional hydroxy terminating poly(N-vinyl pyrrolidone) conjugated superoxide dismutase
43. Oxygen radicals in influenza induced pathogenesis and treatment with pyran polymer-conjugated SOD
44. Synthesis of the conjugate of superoxide dismutase with the copolymer of divinyl ether and maleic anhydride retaining enzymatic activity
45. Modification of physico-chemical and biopharmaceutical properties of superoxide dismutase by conjugation to the copolymer of divinyl ether and maleic anhydride
46. Enhanced anti-inflammatory effects and reduced immunogenicity of bovine liver superoxide dismutase by conjugation with homologous albumin
47. Effect of lecithinized-superoxide dismutase on the interstitial pneumonia model induced by bleomycin in mice
48. Lecithinized superoxide dismutase induces vasodilation: Evidence of direct contribution of superoxide anions to modulating vascular tone
49. Lecithinized superoxide dismutase attenuates phorbol myristate acetate-induced injury in isolated dog lung
50. Effect of lecithinized superoxide dismutase (PC-SOD) on experimental pulmonary metastasis in mice
51. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase
52. Preparation of a polyethylene glycol: Superoxide dismutase adduct, and an examination of its blood circulating life and anti-inflammatory activity
53. A new procedure for the synthesis of polyethylene glycol-protein adducts: Effects on function, receptor recognition and clearance of superoxide dismutase, lactoferrin and b-2-macroglobulin
54. Surface modification of proteins: Activation of monomethoxy-polyethylene glycol by phenylchloroformates and modification of ribonuclease and superoxide dismutase
55. Anti-inflammatory properties of superoxide dismutase derivatives (SOD-PEG-3 and SOD-PEG-18) in carrageenan pleurisy
56. PEG superoxide dismutase derivatives: Anti-inflammatory activity in carrageenan pleurisy in rats
57. Immunogenicity of polyethylene glycol-modified superoxide dismutase and catalase
58. Anti-inflammatory and pharmacokinetic properties of superoxide dismutase derivatized with polyethylene glycol via active esters
59. Plasma clearance and immunologic properties of long-acting superoxide dismutase prepared using 35,000 to 120,000 dalton polyethylene glycol
60. Augmentation of antioxidant enzymes in vascular endothelium
61. Mitigation of pulmonary oxygen toxicity in premature lambs with intravenous antioxidants
62. Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance
63. Improvement of therapeutic effect of human recombinant superoxide dismutase on ischaemic acute renal failure in the rat via cationization and conjugation with polyethylene glycol
64. Evaluation of monomethoxypolyethyleneglycol derivatized superoxide dismutase in blood and evidence for its binding to blood cells
65. Preparation, physico-chemical and pharmacokinetic characterization of monomethoxypoly(ethylene glycol)-derivatized superoxide dismutase
66. Anti-inflammatory activity of monomethoxypolyethylene glycol superoxide dismutase on adjuvant arthritis in rats
67. Superoxide dismutase modifications for anti-inflammatory therapy
68. Distribution of catalase, ribonuclease and superoxide dismutase modified by monomethoxy (polyethylene glycol) into rat central lymph and lymphatic nodes
69. Polyethylene glycol-superoxide dismutase inhibits lipid peroxidation in hepatic ischemia/reperfusion injury
70. 2 derivative
71. Reduction of lipid peroxidation with intraoperative superoxide dismutase treatment decreases intimal hyperplasia in experimental vein grafts
72. Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity
73. Effect of free radical scavengers on diaphragmatic fatigue
74. Targeted delivery and improved therapeutic potential of catalase by chemical modification: Combination with superoxide dismutase derivatives
75. Targeting of superoxide dismutase and catalase to vascular endothelium
76. Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives
77. Manipulation of renal disposition of human recombinant superoxide modification
78. Inhibition of oxygen toxicity by targeting superoxide dismutase to endothelial cell surfaces
79. 10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain
80. Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia
81. Plasma pharmacokinetics, nervous system biodistribution and biostability, and spinal cord permeability at the blood-brain barrier of putrescine-modified catalase in the adult rat
82. Superoxide dismutase, an enzymatic function for erythrocuprein
83. Some chemical and pharmacological properties of a novel anti-inflammatory protein
84. Bovine erythrocyte superoxide dismutase complete amino acid sequence
85. Total reconstitution of copper-zinc superoxide dismutase
86. X-ray absorption edge spectroscopy of Co(II)-binding sites of copper- and zinc-containing proteins
87. 2SOD. Histidine-44 is detached upon anion binding
88. Competitive inhibition of Cu,Zn superoxide dismutase by monovalent anions
89. Peptide synthesis in water and the use of immobilized carboxypeptidase Y for deprotection
90. Functionalization of poly(ethylene glycol) and monomethoxy-poly(ethylene glycol)
91. An improvement of 2,4,6-trinitrobenzenesulfonic acid method for determination of amines
92. Determination of free amino groups in proteins by trinitrobenzene-sulfonic acid
93. Fluorescamine: A reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range
94. A direct assay for evaluation of polyethylene glycol in enzyme adducts used as drugs or biocatalysts
95. Accurate evaluation method of the polymer content in monomethoxy(polyethylene glycol) modified proteins based on amino acid analysis
96. Comparison of results of various methods used to determine the extent of modification of methoxy polyethylene glycol 500-modified bovine Cu-Zn superoxide dismutase
97. 2O structure of PEG solutions
98. Characterization of the heterogeneicity of polyethylene glycol-modified superoxide dismutase by chromatographic and electrophoretic techniques
99. Electrophoresis of polyethylene glycols and related materials as sodium dodecyl sulfate complexes
100. A comparative study of enzymatic, structural and pharmacokinetic properties of superoxide dismutase isolated from two sources and modified by monomethoxypoly(ethylene glycol) using different methods of coupling. Enzyme Engineering 10
101. New methods for the preparation of biospecific adsorbents and immobilized enzymes utilizing trichloro-s-triazine
102. A strategy for characterization of polyethylene glycol-derivatized proteins. A mass spectrophotometric analysis of the attachment site in polyethylene glycol-derivatized superoxide dismutase
103. Prolongation of serum half-life period of superoxide dismutase by poly(ethylene glycol) modification
104. Synthesis and characterization of superoxide dismutase-deferoxamine conjugate via polyoxyethylene: A new molecular device for removal of a variety of reactive oxygen species
105. Subcutaneous administration of superoxide dismutase entrapped in long circulating liposomes: In vivo fate and therapeutic activity in an inflammation model
106. 125I-superoxide dismutase in mice
107. Pharmacokinetic properties of polyethylene glycol derivatized superoxide dismutase
108. Diabetes insipidus in uricase-deficient mice: Model for evaluating therapy with poly(ethylene glycol)-modified uricase
109. Conjugation of high-molecular weight poly(ethylene glycol) to cytokines: Granulocyte-macrophage colony-stimulating factors as model substrates. Poly(ethylene glycol) Chemistry and Biological Applications
110. Preparation of long-acting superoxide dismutase using high molecular weight polyethylene glycol (41,000-72,000 daltons)
111. Pharmacokinetics and tolerability of ventricularly administered superoxide dismutase in monkeys and preliminary clinical observations in familial ALS
112. Enhanced rates of fluid pinocytosis during exponential growth and monolayer regeneration by cultured arterial exponential cells
113. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits
114. Effect of lipid feeding on endothelium dependent relaxation in rabbit aortic preparations
115. Impairment of endothelium-dependent relaxation: An early marker for atherosclerosis in the rabbit
116. Effect of hypercholesterolemia on vascular reactivity in the rabbit
117. Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates
118. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta
119. Selective attenuation of endothelium-mediated vasodilatation in atherosclerotic human coronary arteries
120. Endothelium-dependent relaxation and experimental atherosclerosis in the rabbit aorta
121. Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: Implications for altered autocrine and paracrine functions of EDRF
122. Vascular effects of oxygen-derived free radicals
123. Lipid peroxidation and endothelial cell injury: Implications in atherosclerosis
124. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
125. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
126. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition and prevention
127. Pantency results of percutaneous and surgical revascularization for femoropopliteal arterial disease
128. Towards a solution for saphenous vein graft failure
129. Pathophysiology of vein graft failure
130. Control of the structural and functional consequences of vein graft intimal hyperplasia with a 21-aminosteroid (U74389G)
131. Stranger in a strange land: The pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries
132. Lipid peroxidation: A possible factor in late graft failure of coronary artery bypass grafts
133. Arterial wall oxygenation, oxyradicals, and atherosclerosis
134. Free radicals, antioxidants and human disease: Where are we now?
135. Effects of polyethylene-modified superoxide dismutase on reperfusion induced arrhythmias in isolated rat and guinea pig hearts
136. Effect of some free radical scavengers on reperfusion-induced arrhythmias in the isolated rat heart
137. Reperfusion-induced arrhythmias and oxygen-derived free radicals: Studies with 'anti-free radical' interventions and a free radical-generating system in the isolated perfused rat heart
138. Potential electrophysiologic mechanisms responsible for dysarrhythmias associated with reperfusion of ischemic myocardium
139. Reperfusion arrhythmia: A marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardium infarction
140. Creatine phosphate: An additive myocardial protective and antiarrhythmic agent in cardioplegia
141. Ventricular fibrillation caused by myocardial reperfusion in Prinzmetal's angina
142. Pretreatment with a single bolus injection of polyoxyethylene-modified superoxide dismutase prevents reperfusion induced arrhythmias in the anesthetized rat
143. Reperfusion-induced arrhythmias: Mechanisms and prevention
144. Evidence against the 'early protection-delayed death' hypothesis of superoxide dismutase therapy in experimental myocardial infarction
145. The independent effects of oxygen radical scavengers on canine infarct size. Reduction by superoxide dismutase but not catalase
146. Xanthine oxidase as a source of free radical damage in myocardial ischemia
147. Superoxide dismutase and catalase reduce infarct size in a porcine myocardial occlusion-reperfusion model
148. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart
149. Polyethylene glycol-conjugate superoxide dismutase protects rats against oxygen toxicity
150. Potentiation of diffuse lung damage by oxygen: Determining variables
151. Pulmonary inflammation due to oxygen toxicity: Involvement of chemotactic factor and polymorphonuclear leukocytes
152. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria
153. Polyethylene glycol-attached antioxidant enzymes decrease pulmonary oxygen toxicity in rats
154. Dexamethasone and indomethacin modify endotoxin-induced respiratory failure in pigs
155. Effect of polyethylene glycol-superoxide dismutase and catalase on endotoxemia in pigs
156. Polyethylene glycol-conjugated superoxide dismutase attenuates septic lung injury in guinea pigs
157. The risk factors, incidence, and prognosis of ARDS following septicemia
158. The incidence of the adult respiratory distress syndrome
159. Oxygen-dependent microbial killing by phagocytes
160. Granulocytes mediate acute edematous lung injury in rabbits and in isolated rabbit lungs perfused with phorbol myristate acetate: Role of oxygen radicals
161. Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid
162. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance
163. Alteration of superoxide dismutase (SOD) activity in tracheal epithelial cells by asbestos and inhibition of cytotoxicity by antioxidants
164. Prevention of asbestos-induced cell death in rat lung fibroblasts and alveolar macrophages by scavengers of active oxygen species
165. Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages
166. ·) from alveolar macrophages exposed to asbestiform and nonfibrous particles
167. Asbestos effects on superoxide production: An in vitro study of hamster alveolar macrophages
168. Chemiluminescence of asbestos-activated macrophages
169. Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia-reperfusion
170. Oxygen-derived free radicals in postischemic tissue injury
171. Superoxide production in experimental brain injury
172. Oxygen radicals mediate the cerebral arteriolar dilation from arachidonate and bradykinin in cats
173. Polyethylene glycol-conjugated superoxide dismutase fails to augment brain superoxide dismutase activity in piglets
174. Superoxide dismutase and catalase failed to improve neurologic outcome after complete cerebral ischemia in the dog
175. The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion
176. Brain edema and cerebrovascular permeability during cerebral ischemia in rats
177. Protective effect of superoxide dismutase and polyethylene glycol-linked superoxide dismutase against renal warm ischemia/reperfusion injury
178. Ablation of free-radical mediated reperfusion injury for the salvage of kidneys taken from non-heartbeating donors
179. Protective effect of allopurinol and superoxide dismutase in renal isografts in cyclosporin A-treated rats
180. Lack of effect of oxygen-radical scavenging systems in the preserved reperfused rabbit kidney
181. A randomized double-blind trial of the use of human recombinant superoxide dismutase in renal transplantation
182. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants
183. PEG-SOD and myocardial protection
184. Reperfusion injury
185. Neutrophils, cytokines, and adhesion molecules in hepatic ischemia and reperfusion injury
186. Influence of oxygen-derived free radical scavengers on ischemic livers
187. The potential role of reactive oxygen species in liver ischemia/reperfusion injury following liver surgery
188. Determination of aldehydic lipid peroxidation products: Malonaldehyde and hydroxymonenal
189. Malonaldehyde determination as index of lipid peroxidation